Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
Biofrontera Inc. (Nasdaq: BFRI) has announced that CEO Erica Monaco will present at the Roth Inaugural Healthcare Opportunities Conference on October 6, 2022, at 8:30 a.m. Eastern Time in New York City.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Biofrontera Inc. (Nasdaq: BFRI) has announced that CEO Erica Monaco will present at the Roth Inaugural Healthcare Opportunities Conference on October 6, 2022, at 8:30 a.m. Eastern Time in New York City. The company invites investors attending the conference to schedule one-on-one meetings with management.
Biofrontera specializes in dermatological products, focusing on treatments like photodynamic therapy and topical antibiotics for conditions such as actinic keratoses and impetigo.
Details
News Market Reaction – BFRI
The recorded move for BFRI in the trading session of this news was +5.24%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale Club in New York City on October 6, 2022. Management will also be participating in one-on-one investor meetings at the conference.
| Event: | Roth Inaugural Healthcare Opportunities Conference |
| Date: | Thursday, October 6, 2022 |
| Time: | 8:30 a.m. Eastern Time |
Investors registered for the conference are encouraged to contact their Roth representative to schedule a one-on-one meeting with management during the conference.
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.
Contacts:
Biofrontera Inc.
Anke zur Mühlen
+1 781 486 1539
us-ir@biofrontera.com
LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com
# # #
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.